- Home
- IVA vs TTI Comparison
IVA vs TTI Comparison
Compare IVA & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- TTI
- Stock Information
- Founded
- IVA 2011
- TTI 1981
- Country
- IVA France
- TTI United States
- Employees
- IVA N/A
- TTI N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- TTI Oil & Gas Production
- Sector
- IVA Health Care
- TTI Energy
- Exchange
- IVA Nasdaq
- TTI Nasdaq
- Market Cap
- IVA 359.6M
- TTI 363.3M
- IPO Year
- IVA 2020
- TTI 1990
- Fundamental
- Price
- IVA $3.62
- TTI $2.99
- Analyst Decision
- IVA Strong Buy
- TTI Strong Buy
- Analyst Count
- IVA 4
- TTI 2
- Target Price
- IVA $10.50
- TTI $5.25
- AVG Volume (30 Days)
- IVA 22.8K
- TTI 1.2M
- Earning Date
- IVA 03-26-2025
- TTI 04-29-2025
- Dividend Yield
- IVA N/A
- TTI N/A
- EPS Growth
- IVA N/A
- TTI 426.72
- EPS
- IVA N/A
- TTI 0.84
- Revenue
- IVA $14,591,573.00
- TTI $605,279,000.00
- Revenue This Year
- IVA $15.38
- TTI $2.67
- Revenue Next Year
- IVA $24.22
- TTI $7.55
- P/E Ratio
- IVA N/A
- TTI $3.58
- Revenue Growth
- IVA N/A
- TTI N/A
- 52 Week Low
- IVA $1.53
- TTI $2.03
- 52 Week High
- IVA $4.05
- TTI $5.12
- Technical
- Relative Strength Index (RSI)
- IVA 58.88
- TTI 58.40
- Support Level
- IVA $3.13
- TTI $2.65
- Resistance Level
- IVA $3.54
- TTI $2.82
- Average True Range (ATR)
- IVA 0.27
- TTI 0.12
- MACD
- IVA 0.02
- TTI 0.01
- Stochastic Oscillator
- IVA 69.66
- TTI 86.59
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.